Creative Planning - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 44 filers reported holding BIOXCEL THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Creative Planning ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$53,697
-81.0%
21,224
+226.7%
0.00%
-100.0%
Q3 2020$282,000
+15.6%
6,497
-40.5%
0.00%0.0%
Q1 2020$244,000
+12.4%
10,914
-26.5%
0.00%0.0%
Q4 2019$217,000
+24.0%
14,850
-7.2%
0.00%0.0%
Q2 2019$175,000
-42.1%
16,000
-47.6%
0.00%0.0%
Q1 2019$302,000
+196.1%
30,550
+128.8%
0.00%
Q3 2018$102,00013,3500.00%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
PVG ASSET MANAGEMENT CORP 15,040$177,772,0000.69%
AlphaCentric Advisors LLC 50,000$591,0000.61%
Artemis Investment Management LLP 1,374,496$16,260,0000.18%
Knoll Capital Management, LLC 20,000$236,0000.14%
Game Plan Financial Advisors, LLC 11,280$133,0000.11%
Virtus ETF Advisers LLC 11,365$134,0000.05%
AllSquare Wealth Management LLC 5,527$65,0000.05%
Hennion & Walsh Asset Management, Inc. 34,231$405,0000.03%
Aquatic Capital Management LLC 10,000$118,0000.01%
Jump Financial, LLC 26,000$307,0000.01%
View complete list of BIOXCEL THERAPEUTICS INC shareholders